Assystem - Registration Document 2016

4

2016 CORPORATE SOCIAL RESPONSIBILITY REPORT (CSR)

THE ASSYSTEM GROUP’S CSR STRATEGY

Four engineering students who joined Assystem for their final year internship have been selected to assist Clinatec with this project. The partnership is symbolic of Assystem’s values and convictions in that it is meaningful for society as a whole, for Assystem and for the Group’s young employees. Research into the application of biotechnology to disabilities carries a powerful promise of social progress that reflects the Group’s commitments. The collaboration with Clinatec also forms part of an open innovation process based on co-development and experimentation, in line with the incubator strategy deployed through the Assystem Innovation Factory. The process of co-creation with all of the Group’s stakeholders – employees, shareholders, clients and the community – is the key to opening up possibilities and advances that are the driving force of Assystem’s engineering business. By supporting this project, Assystem will acquire expertise in complex technologies that will shape the future and can ultimately also be used in other sectors. At the first ABNL Non-Profit Awards ceremony organised by BFM Business in November 2016, Thierry Bosc, Clinatec’s Campaign Manager, and Philippe Eyssautier, Assystem’s business development director, received the “Healthcare and Research” award from Hugues Renson, managing director of the EDF Foundation, and Sophie Barniaud, co-founder of Carenews.

Assystem has developed an app that converts an Android tablet into a touch panel for the test sets marketed by Germany’s Omicron. Designed according to the Bring Your Own Device (BYOD) principle, the CMControl app is the first autonomous operating system for the Omicron test sets used by companies in the electricity, manufacturing, railway switchgear and measuring equipment industries. The tablet’s Wi-Fi connection gives its user greater freedom of movement, and the test reports created by the system can be viewed and assessed directly on the tablet. This solution developed by Assystem’s teams in just three months enabled Omicron to score a market first with an attractive new operating concept, thanks to the development cost savings achieved through equipment personalisation. In 2016, the same technology enabled the introduction of a largely paperless quality inspection process in Airbus cabins, reducing the inspection time by half and making life a lot easier for the inspectors. The medicine of the future In early 2016, Assystem signed a partnership agreement with Clinatec, a cutting-edge research centre that develops innovative biomedical systems for the medicine of the future. The Group is working with Clinatec on a Brain Computer Interface project which aims to demonstrate that it is possible to drive an exoskeleton thanks to an implant that records cortical signals, with the ultimate goal of helping quadriplegics to become more independent.

48

ASSYSTEM

REGISTRATION DOCUMENT 2016